Equity capital markets

Shield Therapeutics

Advised Shield on its AIM IPO and on its subsequent secondary fundraising. Shield is a commercial stage pharmaceutical company with an initial focus on iron deficiency.

BTG

Advised BTG on its £160 million equity fundraising to fund the acquisition of PneumRX.

Novacyt S.A.

Advised medical diagnostics company, Novacyt, on its London AIM IPO in conjunction with its Paris Euronext Growth listing.

TyraTech Inc.

Advised AIM listed life sciences company TyraTech on its tender offer to shareholders following the sale of its Vamousse product to Alliance Pharma PLC. 

More: Equity capital markets

Restructuring and insolvency

Baker Tilly

Advised Baker Tilly on its acquisition of RSM Tenon by way of pre-pack administration.

Pension Protection Fund

Advised on the restructuring of Monarch Airlines.

More: Restructuring and insolvency

Public and private M&A

Lavendon Group plc

Advised Lavendon on the contested takeover battle between Loxam and TVH which resulted in the £459 million takeover by Loxam of Lavendon following what The Times described as "one of the most extraordinary bid battles on the London market in recent times."

ENGIE

Advised ENGIE on its £330 million acquisition of Keepmoat, the UK's leading provider of regeneration services for local authorities.

BTG plc

Advised BTG on its $475 million acquisition of PneumRx Inc and £160 million equity fundraising.

Advised BTG on its successful recommended bid for Biocompatibles International plc.

Acadia Healthcare

Advising this Tennessee headquartered behavioural health facilities provider on its £1.5 billion take over of the Priory Group and on its $660 million acquisition of Partnerships in Care.

Baker Tilly (now re-named RSM)

Advising the UK's 9th largest accountancy practice on the acquisition of RSM Tenon, then the UK's 7th largest accountancy practice.

TechnoNICOL

Advised the largest Russian and European manufacturer and supplier of roofing and insulation materials on its first UK acquisition, of Superglass Holdings PLC.

De Vere

Advised De Vere on the sale of The Grand Hotel, Brighton.

ENGIE

Advised ENGIE on its £190 million acquisition of Balfour Beatty Workplace facilities management business.

Yusen Logistics

Advised Yusen Logistics on its acquisition of Romanian logistics business, Tibbett Logistics.

More: Public and private M&A

Projects and infrastructure

ENGIE

Advised ENGIE on its takeover of certain of Carillion's contracts with the Northern Ireland Housing Executive.

Equitix

Advised Equitix on the acquisition of part of Laing O'Rourke's BSF portfolio.

Dutch Infrastructure Fund

Advised the fund on its acquisition of stakes in two Irish motorway PPP projects.

ENGIE

Advised ENGIE on its acquisition of Lend Lease Facilities Management Limited

More: Projects and infrastructure

Joint ventures

Kernal Holdings

Tristan Capital

JP Morgan

Life sciences

Shield Therapeutics

Advised Shield on its AIM IPO and on its subsequent secondary fundraising. Shield is a commercial stage pharmaceutical company with an initial focus on iron deficiency.

BTG plc

Advised on its $475 million acquisition of PneumRx Inc and £160 million equity fundraising.

Advised on its acquisition of EKOS Corporation Inc for $180 million.

Piramal Healthcare

Advised on the US$3.8 billion disposal of its Indian branded prescription generics business to Abbot.

Advised on its acquisition and subsequent disposal of Bayer's molecular imaging diagnostics business.

Novacyt S.A.

Advised medical diagnostics company, Novacyt, on its London AIM IPO in conjunction with its Paris Euronext Growth listing.

TyraTech Inc.

Advised AIM listed life sciences company TyraTech on its tender offer to shareholders following the sale of its Vamousse product to Alliance Pharma PLC.

Protherics plc

Advised on its acquisition by BTG plc to form the UK's largest listed biopharmaceutical company.

More: Life sciences

UK

Lavendon Group plc

Advised Lavendon on the contested takeover battle between Loxam and TVH which resulted in the £459 million takeover by Loxam of Lavendon following what The Times described as "one of the most extraordinary bid battles on the London market in recent times."

ENGIE

Advised ENGIE on its £330 million acquisition of Keepmoat, the UK's leading provider of regeneration services for local authorities.

Acadia Healthcare

Advising this Tennessee headquartered behavioural health facilities provider on its £1.5 billion take over of the Priory Group and on its $660 million acquisition of Partnerships in Care.

BTG plc

Advising on its successful recommended bid for Biocompatibles International plc.

Baker Tilly (now re-named RSM)

Advising the UK's 9th largest accountancy practice on the acquisition of RSM Tenon, then the UK's 7th largest accountancy practice.

De Vere

Advising on the sale of The Grand Hotel, Brighton.

ENGIE

Advised ENGIE on its £190 million acquisition of Balfour Beatty Workplace facilities management business.

CIS and CEE

Rusal Ltd

Advising on its US$30 billion merger with SUAL and the alumina assets of Glencore International to form United Company Rusal Ltd.

United Company Rusal Ltd

Advising this company and its majority shareholder (EN+Group Ltd) on the US$14 billion acquisition of a 25% stake in Russian copper and nickel miner Norilsk Nickel.

STADA Arzneimittel

Advised on its acquisition of Russian generics pharmaceutical company Nizhpharm. 

TechnoNICOL

Advised the largest Russian and European manufacturer and supplier of roofing and insulation materials on its first UK acquisition, of Superglass Holdings PLC.

More: CIS and CEE

India

Piramal Enterprises

Advised on the US$3.8 billion disposal of its Indian branded prescription generics business to Abbot.

Advised on its acquisition and subsequent disposal of Bayer's molecular imaging diagnostics business.

Advised on the acquisition of a pharmaceuticals manufacturing site from Pfizer.